NLS Prio

Prio - June 18, 2019

Pharma industry confronts growing problem of pharmaceutical waste

Pharmaceuticals in the environment is a growing problem of global concern. Drugs taken by humans and animals find their way into rivers, lakes and even drinking water and can have devastating effects on both aquatic and human health.

Prio - March 1, 2019

Mini-Interview: Miguel Forte, CEO of Zelluna

Zelluna, a biopharmaceutical company founded in 2016, focuses on the development of T-Cell Receptor (TCR) based immunotherapies. The company has several TCRs in different stages of development. “We are developing cell therapies for solid tumors by genetically engineering the surface receptors of patient lymphocytes. We are also targeting cancer via the immune system, utilizing lymphocytes,” […]

Collaboration - September 19, 2018

Tampere – A perfect location for R&D and Innovation

Located between two lakes, Näsijärvi and Pyhäjärvi, Finland’s Manchester possesses a vibrant ecosystem, supporting life science collaborations across disciplines. In a beautiful Finnish landscape consisting of lakes and nature reserves, and with characteristic red brick buildings revealing the industrial history, lies Finland’s second largest city region with close to half a million inhabitants. The city […]

Prio - May 15, 2018

Oslo – Making its mark in cancer studies and multidisciplinary research

For centuries, Oslo has been Norway’s undisputed center of government, industry and culture, and now it is becoming one of the nation’s and region’s major life science hubs. Home to a top university and hospital, as well as a major cancer research coalition, the city is making its mark in cancer studies and multidisciplinary research. Life […]

Prio - March 27, 2018

Life Science Billion Makers

Ironically, there is less serendipity in the success Saeid Esmaeilzadeh and Ashkan Pouya have achieved as business-makers than there is traditional hard work.

Prio - March 27, 2018

Building a life science business – Balancing risk and vision

Tanja Dowe, Head of Debiopharm Innovation Fund, gives us her insights from the hard but exciting work of building a life science business and what it takes to make it in an ever rapidly changing industry.

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.